Abstract
Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40% and 38%, respectively; diabetes prevalence of 21% and 22%; and smoking prevalence of 37% and 48%. Hypertension treatment was higher among HIV+ than HIV- women (77% vs. 67%, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56% vs. 43%, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48% vs. 49%) and increased over time in both groups. Diabetes control was greater among HIV+ women (73% vs. 64%, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10% vs. 9%), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 445-454 |
| Number of pages | 10 |
| Journal | AIDS Patient Care and STDs |
| Volume | 30 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2016 |
Fingerprint
Keywords
- antiretroviral therapy
- cardiovascular disease
- diabetes mellitus
- HIV-1 viral load
- hypertension
- smoking
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Infectious Diseases
Cite this
Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. / Hanna, David B.; Jung, Molly; Xue, Xiaonan (Nan); Anastos, Kathryn; Cocohoba, Jennifer M.; Cohen, Mardge H.; Golub, Elizabeth T.; Hessol, Nancy A.; Levine, Alexandra M.; Wilson, Tracey E.; Young, Mary A.; Kaplan, Robert C.
In: AIDS Patient Care and STDs, Vol. 30, No. 10, 01.10.2016, p. 445-454.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy
AU - Hanna, David B.
AU - Jung, Molly
AU - Xue, Xiaonan (Nan)
AU - Anastos, Kathryn
AU - Cocohoba, Jennifer M.
AU - Cohen, Mardge H.
AU - Golub, Elizabeth T.
AU - Hessol, Nancy A.
AU - Levine, Alexandra M.
AU - Wilson, Tracey E.
AU - Young, Mary A.
AU - Kaplan, Robert C.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40% and 38%, respectively; diabetes prevalence of 21% and 22%; and smoking prevalence of 37% and 48%. Hypertension treatment was higher among HIV+ than HIV- women (77% vs. 67%, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56% vs. 43%, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48% vs. 49%) and increased over time in both groups. Diabetes control was greater among HIV+ women (73% vs. 64%, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10% vs. 9%), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.
AB - Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure <140/90 mmHg), diabetes treatment and control (fasting glucose <130 mg/dL), and smoking quit rates in the Women's Interagency HIV Study. Unadjusted and adjusted Poisson regression models tested time trends and differences between HIV+ and HIV- women. Among antiretroviral therapy (ART) users, we examined the association of ART adherence and virologic suppression with each outcome. We evaluated 1636 HIV+ and 683 HIV- women, with a hypertension prevalence of 40% and 38%, respectively; diabetes prevalence of 21% and 22%; and smoking prevalence of 37% and 48%. Hypertension treatment was higher among HIV+ than HIV- women (77% vs. 67%, p < 0.001) and increased over time with no difference in trend by HIV status. Hypertension control was greater among HIV+ women (56% vs. 43%, p < 0.001) and increased over time among HIV+ but not HIV- women. Diabetes treatment was similar among HIV+ and HIV- women (48% vs. 49%) and increased over time in both groups. Diabetes control was greater among HIV+ women (73% vs. 64%, p = 0.03) and did not change over time. The percent of recent smokers who reported no longer smoking was similar between HIV+ and HIV- women (10% vs. 9%), with no differences over time. Virologic suppression was significantly associated with increased hypertension treatment and greater control. HIV+ women have better control of hypertension and diabetes than HIV- women, but many are still not at target levels.
KW - antiretroviral therapy
KW - cardiovascular disease
KW - diabetes mellitus
KW - HIV-1 viral load
KW - hypertension
KW - smoking
UR - http://www.scopus.com/inward/record.url?scp=84992036356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992036356&partnerID=8YFLogxK
U2 - 10.1089/apc.2016.0143
DO - 10.1089/apc.2016.0143
M3 - Article
C2 - 27749112
AN - SCOPUS:84992036356
VL - 30
SP - 445
EP - 454
JO - AIDS Patient Care and STDs
JF - AIDS Patient Care and STDs
SN - 1087-2914
IS - 10
ER -